CEL-SCI (CVM)'s Taiwanese Partner Orient Europharma Co., Ltd. Presents Development Strategies in Taiwan for Investigational Cancer Therapy Multikine (Leukocyte Interleukin, Injection) at World Orphan Drug Conference Today in Seoul, Korea
9/15/2011 10:20:22 AM
More...
|
CEL-SCI (CVM) Announces Start of Multikine Phase III Study by Orient Europharma Co., Ltd. in Taiwan
6/23/2011 8:32:48 AM
More...
|
Medinox, Inc. and Orient Europharma Co., Ltd. Announce Collaboration on Developing NOX-100, a New Anti-Hypotensive Drug
4/12/2010 9:05:46 AM
More...
|